A vaccine combining centralized ancestral genes from four major influenza strains appears to provide broad protection against the dangerous ailment, according to new research by a team from the Nebraska Center for Virology.
Mice protected by the unconventional vaccine survived exposure to lethal doses of seven of nine widely divergent influenza viruses. Those that received higher doses of the vaccine didn’t even get sick.
In contrast, mice that received traditional flu shots or nasal sprays all sickened and died when exposed to the same viruses. The deadly pathogens were able to evade the immune responses triggered by the traditional vaccines.
While it is too soon to say the approach could be successfully used in humans, it appears to be a promising avenue toward a universal flu shot, according to lead researcher Eric Weaver, an assistant professor in the School of Biological Sciences at the University of Nebraska-Lincoln.
Weaver said the study is the first to report on whether a universal flu shot could be created by using a combination of multiple genes shared at the ancestral level by flu strains circulating today.
“The ultimate goal is to be able to vaccinate once and provide lifelong protection,” Weaver said.
The Centers for Disease Control and Prevention estimates that 40 million Americans contracted influenza during the 2015-16 flu season and 970,000 people were hospitalized for the ailment. The agency estimated that vaccinations prevented about 1.9 million illnesses and 67,000 hospitalizations.
“To put this in other terms, our current influenza vaccine programs and technologies reduce influenza infections and hospitalizations by 4.75 percent and 6.9 percent, respectively,” Weaver said. “There is no doubt that there is a need for more effective vaccine technologies.”
Yet because the influenza virus mutates rapidly and because people, animals and birds often carry the virus without displaying symptoms, it’s been difficult to develop a vaccine with long-term effectiveness. The conventional influenza vaccine platform uses weakened or dead versions of the influenza virus to stimulate immunity against hemagglutinin (HA), a spike-shaped protein that extends from the surface of the virus and attacks cells.
According to a 2013 Clinical Microbiology Reviews article, the challenges of the conventional approach include predicting which flu strain will circulate in coming years; manufacturing and delivering safe, timely and adequate supplies; and poor responsiveness among the elderly, who often are the most vulnerable to influenza infection.
Conventional vaccines have been shown to be less than 60 percent effective when they’re successfully matched to the currently circulating strain. They’re far less effective when mismatched.
“An ideal influenza vaccine would be inexpensive, provide long-lasting immunity, require few immunizations and would work against all variants of the virus,” Weaver said.
Some experts say it could take until 2020 or 2025 before a universal flu vaccine is available.
Pursuit of a universal influenza vaccine has been difficult. Scientists are trying various approaches to better match vaccines to multiple viral strains. Other strategies include developing vaccines aimed at the virus’s protein coat, other proteins that have been found to be identical in multiple flu strains, or the stalk of the hemagglutinin protein rather than its head.
These approaches have shown promising results. However, Weaver said his study is the first to report the use of multiple centralized HA genes, identified using protein sequence analysis programs, to provide the greatest level of cross-protective immunity possible.
In the article published Nov. 2 in Scientific Reports, Weaver and his colleagues Amy Lingel and Brianna L. Bullard detail an approach they say is “scalable and translatable to humans and may provide the foundation for complete and long-lasting anti-influenza immunity.”
The idea arose from past research led by Dr. Bette Korber at Los Alamos National Laboratories to discover the ancestral genes for the Human Immunodeficiency Virus and to pinpoint when that virus jumped from monkeys to man. Weaver was involved with that effort while a post-doctoral researcher at Duke University School of Medicine. He and his colleagues decided to try a similar concept with the influenza virus, synthesizing genes that are central to influenza’s phylogenetic tree.
Instead of using weakened or deadened flu virus, his experiments at the Nebraska Center for Virology have used replication-defective Adenoviruses – which cause the common cold – that have been altered to carry what he calls consensus genes for H1, H2, H3 and H5 influenza strains. The vaccine is no longer capable of causing cold symptoms, but is still able to safely deliver the influenza vaccine genes.
“Our idea is that these centralized antigens can set up a foundation of immunity against influenza,” he said. “Because they are centralized and represent all the strains equally, they could provide a basis for immunity against all evolved strains.”
The Latest on: Flu vaccine
- Get your flu vaccine at The Discovery! Immunize Nevada to hold free clinic next weekon October 18, 2019 at 1:07 pm
Get your flu vaccine at The Discovery! Immunize Nevada to hold free clinic next week Immunize Nevada is hosting a free flu vaccine clinic at The Discovery on Wednesday. Check out this story on rgj.com ...
- Fact Check: Instagram post falsely links flu vaccine to Polioon October 18, 2019 at 12:20 pm
The post has racked up nearly 11,000 ‘likes’ in four days. But each of its claims is either unsubstantiated, false or misleading. The flu shot is the single best way to protect against seasonal ...
- Instagram Post Falsely Links Flu Vaccine to Polioon October 18, 2019 at 11:00 am
The flu vaccine cannot give anyone polio and there is no evidence to support the 1,100 figure. Just as flu season is kicking into gear in the U.S., an Instagram post is spreading false and misleading ...
- Primary schools forced to cancel flu vaccine sessions in Englandon October 18, 2019 at 7:25 am
Parents have been left anxious that their children have not been able to get the nasal spray, known as Fluenz or LAIV, which means live attenuated influenza vaccine. A patient at the Victoria Medical ...
- Pregnant women must get their flu shots to help avoid future influenza epidemicson October 18, 2019 at 3:35 am
Subscribe to their newsletter to get even more science sent straight to you. The international healthcare and economic burden of influenza in the United States alone is approximately $11.2 billion ...
- As 2019 Flu Season Nears, a One-Time Vaccine Could Be Available Soonon October 17, 2019 at 4:24 pm
The medical community has had some major breakthroughs towards a more permanent solution: a universal flu vaccine. “The virus changes a lot,” said Florian Krammer, a microbiologist at Mount Sinai’s ...
- Researchers bring us one step closer to universal influenza vaccineon October 17, 2019 at 3:32 pm
The scourge of the influenza virus devastates health and claims many lives worldwide each year. It is especially daunting because vaccines are only protective when they are well matched to the strains ...
- Lack of flu vaccine tailored for seniors prompts Warren County woman to search high and low for flu shoton October 17, 2019 at 9:17 am
While Ohio's Department of Health said Thursday that "flu vaccine manufacturers report that there will be plenty of vaccine for this year's flu season," that's not what one Warren County woman found ...
- Seasonal Influenza Vaccine Market Projected to Deliver Greater Revenues during the Forecast Periodon October 17, 2019 at 3:03 am
Oct 17, 2019 (AmericaNewsHour) -- Seasonal Influenza Vaccine Market is expected to reach more than US$ 4 Billion across the seven major markets (7MM) of the United States, France, Germany, Italy, ...
- Influenza Vaccines Market- Global Growth, Trends, And Forecast To 2025on October 17, 2019 at 2:40 am
Oct 17, 2019 (AmericaNewsHour) -- The global influenza vaccines market size is expected to surpass USD 6 billion by 2025. "Influenza Vaccines Market: Global Industry Analysis, Share, Size, Growth, ...
via Google News and Bing News